DGAP-News: Wacker Chemie AG
/ Key word(s): AGM/EGM
Munich, December 9, 2021 - Due to the ongoing corona pandemic, Wacker Chemie AG has decided to hold next year's Annual Shareholders' Meeting scheduled for May 20, 2022, as a virtual event without the physical presence of its shareholders or their proxies. The chemical company's Supervisory Board approved an Executive Board resolution to that effect yesterday. WACKER's decision is based on a legal provision that allows virtual-only shareholders' meetings in view of future pandemic-related meeting restrictions. In early September, the German Bundestag had extended until end of August 2022 the option to hold Annual Shareholders' Meetings virtually, which was already in effect for this year. "WACKER's top priority here is the participants' health," explains CEO Christian Hartel. "The latest wave of the pandemic is in full swing. In addition, there are novel corona virus mutations, which we cannot foresee at the moment how they will impact infection numbers. As it is currently not clear under what conditions large events requiring attendance can be held next year, we decided to go for a virtual Annual Shareholder's Meeting in 2022," adds Hartel. WACKER will publish its invitation to the virtual Annual Shareholders' Meeting in due course. This press release contains forward-looking statements based on assumptions and estimates of WACKER's Executive Board. Although we assume the expectations in these forward-looking statements are realistic, we cannot guarantee they will prove to be correct. The assumptions may harbor risks and uncertainties that may cause the actual figures to differ considerably from the forward-looking statements. Factors that may cause such discrepancies include, among other things, changes in the economic and business environment, variations in exchange and interest rates, the introduction of competing products, lack of acceptance for new products or services, and changes in corporate strategy. WACKER does not plan to update its forward-looking statements, nor does it assume the obligation to do so. For further information, please contact:
09.12.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | Wacker Chemie AG |
Hanns-Seidel-Platz 4 | |
81737 München | |
Germany | |
Phone: | 0049-89-6279-1633 |
Fax: | 0049-89-6279-2933 |
E-mail: | investor.relations@wacker.com |
Internet: | www.wacker.com |
ISIN: | DE000WCH8881 |
WKN: | WCH888 |
Indices: | MDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1255672 |
End of News | DGAP News Service |
|
1255672 09.12.2021
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.